TRAF6 and lung adenocarcinoma: Another study uncovered that growth inhibition by quinine treatment in lung adenocarcinoma and cervical cancer cell lines is due to the impaired activity of TRAF6, a key regulator of Akt signaling (Liu et al., 2016).